KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Evolent Health (EVH) Accumulated Depreciation & Amortization (2016 - 2025)

Evolent Health has reported Accumulated Depreciation & Amortization over the past 11 years, most recently at $115.9 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $115.9 million for Q4 2025, down 2.13% from a year ago — trailing twelve months through Dec 2025 was $115.9 million (down 2.13% YoY), and the annual figure for FY2025 was $115.9 million, down 2.13%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $115.9 million at Evolent Health, up from $70.8 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for EVH hit a ceiling of $123.4 million in Q4 2023 and a floor of $15.1 million in Q1 2022.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $53.4 million (2022), compared with a mean of $58.6 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 103.22% in 2023 and later decreased 20.5% in 2025.
  • Evolent Health's Accumulated Depreciation & Amortization stood at $60.0 million in 2021, then increased by 11.92% to $67.2 million in 2022, then skyrocketed by 83.67% to $123.4 million in 2023, then dropped by 4.09% to $118.4 million in 2024, then fell by 2.13% to $115.9 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $115.9 million (Q4 2025), $70.8 million (Q3 2025), and $47.2 million (Q2 2025) per Business Quant data.